Quality of Life in Patients With Bladder Cancer
NCT00745355 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2025-05-29
Summary
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.
Conditions
Interventions
- BEHAVIORAL
-
Quality Of Life questionnaires
All patients who agree to participate will be interviewed using a baseline idiographic quality of life assessment prior to surgery and at approximately 6, 12, 18 and 24 months postoperatively. All patients will also be asked to respond to a questionnaire including all standard measures (closed-ended, multiple choice items) before surgery and at approximately 3, 6, 12, 18 and 24 months post-surgery.
Sponsors & Collaborators
-
Albert Einstein College of Medicine
collaborator OTHER -
Northwell Health
collaborator OTHER -
Lenox Hill Hospital
collaborator OTHER -
DeltaQuest Foundation, Inc.
collaborator UNKNOWN -
Lahey Hospital & Medical Center
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Bernard Bochner, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2026-08-31
- Completion
- 2026-08-31
Countries
- United States
Study Locations
More Related Trials
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
NCT07048496 ·Status: RECRUITING ·Phase: NA
-
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
NCT05195515 ·Status: ENROLLING_BY_INVITATION
-
Recovery Support for Bladder Cancer Patients and Caregivers
NCT04055311 ·Status: COMPLETED ·Phase: NA
-
The Personal Patient Profile Decision Support for Patients With Bladder Cancer
NCT05033067 ·Status: COMPLETED ·Phase: NA
-
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NCT05739968 ·Status: RECRUITING ·Phase: NA
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
NCT02688348 ·Status: WITHDRAWN ·Phase: NA
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
NCT02186925 ·Status: UNKNOWN
-
Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
NCT02381912 ·Status: COMPLETED
-
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495 ·Status: RECRUITING
-
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
NCT06009510 ·Status: NOT_YET_RECRUITING
-
The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer
NCT05096533 ·Status: UNKNOWN
-
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT02657486 ·Status: COMPLETED ·Phase: NA
-
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
NCT05945108 ·Status: COMPLETED
-
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
NCT03121768 ·Status: UNKNOWN
-
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT03950362 ·Status: UNKNOWN ·Phase: PHASE2
-
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
NCT01373294 ·Status: COMPLETED ·Phase: PHASE2
-
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
NCT04701918 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
NCT05672615 ·Status: RECRUITING
-
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
NCT04625556 ·Status: RECRUITING
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED